重磅-话题@MedSci

#重磅#

1136篇内容 | 2586人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1549818, encodeId=f1e4154981890, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！单片双药HIV治疗药物多伟托®扩大适应症获批，延展至稳定转换HIV感染者, objectType=article, longId=726569, objectId=f62ae26569e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f62ae26569e6, replyNumber=0, likeNumber=109, createdTime=2022-05-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f62ae26569e6, moduleTitle=重磅！单片双药HIV治疗药物多伟托®扩大适应症获批，延展至稳定转换HIV感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f62ae26569e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549817, encodeId=3c9b154981ecd, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Science重磅：何时吃比吃得少更重要！在适当时间进食可延长寿命三分之一, objectType=article, longId=726407, objectId=67c4e264079b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67c4e264079b, replyNumber=0, likeNumber=89, createdTime=2022-05-10, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67c4e264079b, moduleTitle=Science重磅：何时吃比吃得少更重要！在适当时间进食可延长寿命三分之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67c4e264079b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549816, encodeId=dd62154981690, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！钇90树脂微球治疗结直肠癌肝转移介入手术获成功, objectType=article, longId=726220, objectId=1089e2622012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1089e2622012, replyNumber=0, likeNumber=77, createdTime=2022-05-07, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1089e2622012, moduleTitle=重磅！钇90树脂微球治疗结直肠癌肝转移介入手术获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1089e2622012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549815, encodeId=951c15498152f, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=NEJM重磅证据：大面积急性脑梗也应该及时进行血管内治疗！, objectType=article, longId=726000, objectId=2ff8e26000bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ff8e26000bf, replyNumber=0, likeNumber=77, createdTime=2022-05-04, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ff8e26000bf, moduleTitle=NEJM重磅证据：大面积急性脑梗也应该及时进行血管内治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ff8e26000bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549814, encodeId=1c74154981484, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅里程碑：肺癌创新药第三代ALK抑制剂洛拉替尼在中国获批, objectType=article, longId=725721, objectId=8aebe257213e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aebe257213e, replyNumber=0, likeNumber=78, createdTime=2022-04-30, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aebe257213e, moduleTitle=重磅里程碑：肺癌创新药第三代ALK抑制剂洛拉替尼在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aebe257213e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549813, encodeId=8b1b1549813d7, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=时隔6年！《中国居民膳食指南(2022)》重磅发布, objectType=article, longId=725507, objectId=33a6e2550780, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a6e2550780, replyNumber=0, likeNumber=90, createdTime=2022-04-28, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a6e2550780, moduleTitle=时隔6年！《中国居民膳食指南(2022)》重磅发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a6e2550780)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549812, encodeId=7e071549812d5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=又一重磅名单出炉！首都医科大学吴浩、阴赪宏等75人入选, objectType=article, longId=725456, objectId=f919e25456f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f919e25456f4, replyNumber=0, likeNumber=57, createdTime=2022-04-27, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f919e25456f4, moduleTitle=又一重磅名单出炉！首都医科大学吴浩、阴赪宏等75人入选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f919e25456f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549863, encodeId=05c91549863b6, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Nature重磅：我国干细胞制备技术获重要突破！, objectType=article, longId=725213, objectId=101ce2521363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=101ce2521363, replyNumber=0, likeNumber=73, createdTime=2022-04-27, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=101ce2521363, moduleTitle=Nature重磅：我国干细胞制备技术获重要突破！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=101ce2521363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549811, encodeId=890b154981138, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Circulation：重磅研究！中国胸痛中心大数据揭示空气污染可迅速诱发ACS疾病！, objectType=article, longId=724979, objectId=ee2ce2497948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2ce2497948, replyNumber=0, likeNumber=128, createdTime=2022-04-27, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2ce2497948, moduleTitle=Circulation：重磅研究！中国胸痛中心大数据揭示空气污染可迅速诱发ACS疾病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2ce2497948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549810, encodeId=12371549810be, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, objectType=article, longId=724648, objectId=6f1ce2464888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1ce2464888, replyNumber=0, likeNumber=63, createdTime=2022-04-22, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1ce2464888, moduleTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1ce2464888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549809, encodeId=c467154980979, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！科技部再更新人类遗传资源管理Q&A, objectType=article, longId=724430, objectId=0929e244305c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0929e244305c, replyNumber=0, likeNumber=95, createdTime=2022-04-18, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0929e244305c, moduleTitle=重磅！科技部再更新人类遗传资源管理Q&A, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0929e244305c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549808, encodeId=cdbb1549808d3, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅预告 | 助力癌症防治！鹍远生物“4.15全国肿瘤防治宣传周”活动开启！, objectType=article, longId=724399, objectId=5285e2439966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5285e2439966, replyNumber=0, likeNumber=103, createdTime=2022-04-17, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5285e2439966, moduleTitle=重磅预告 | 助力癌症防治！鹍远生物“4.15全国肿瘤防治宣传周”活动开启！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5285e2439966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549807, encodeId=b5bd154980ea0, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Lancet：柳叶刀重磅！全世界已有38亿人感染过新冠？, objectType=article, longId=724369, objectId=80bae243691c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80bae243691c, replyNumber=0, likeNumber=83, createdTime=2022-04-17, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80bae243691c, moduleTitle=Lancet：柳叶刀重磅！全世界已有38亿人感染过新冠？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80bae243691c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549806, encodeId=4146154980617, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！《2022年新版乳腺癌诊疗指南》正式发布, objectType=article, longId=724304, objectId=e689e243046a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e689e243046a, replyNumber=0, likeNumber=0, createdTime=2022-04-16, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e689e243046a, moduleTitle=重磅！《2022年新版乳腺癌诊疗指南》正式发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e689e243046a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549797, encodeId=acac1549e975c, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=3月精品课top榜单重磅来袭！, objectType=article, longId=724003, objectId=a1f8e24003a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f8e24003a5, replyNumber=0, likeNumber=30, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f8e24003a5, moduleTitle=3月精品课top榜单重磅来袭！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1f8e24003a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549796, encodeId=f9bf1549e9623, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=3月公开课Top榜单重磅来袭！, objectType=article, longId=724002, objectId=8252e24002f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8252e24002f3, replyNumber=0, likeNumber=28, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8252e24002f3, moduleTitle=3月公开课Top榜单重磅来袭！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8252e24002f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549805, encodeId=8d5b1549805ab, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, objectType=article, longId=723990, objectId=9450e23990da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9450e23990da, replyNumber=0, likeNumber=30, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9450e23990da, moduleTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9450e23990da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549804, encodeId=737d1549804e8, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估, objectType=article, longId=723989, objectId=0551e2398931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0551e2398931, replyNumber=0, likeNumber=91, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0551e2398931, moduleTitle=AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0551e2398931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549803, encodeId=7a72154980343, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, objectType=article, longId=723987, objectId=2fc5e239870d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc5e239870d, replyNumber=0, likeNumber=107, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc5e239870d, moduleTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc5e239870d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549801, encodeId=bf8d1549801f8, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=AACR重磅之KGOG 3046/TRU-D：度伐利尤单抗和曲美木单抗联合一线新辅助化疗治疗晚期卵巢癌患者的II期研究, objectType=article, longId=723985, objectId=b52ce23985ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b52ce23985ec, replyNumber=0, likeNumber=42, createdTime=2022-04-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b52ce23985ec, moduleTitle=AACR重磅之KGOG 3046/TRU-D：度伐利尤单抗和曲美木单抗联合一线新辅助化疗治疗晚期卵巢癌患者的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b52ce23985ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重磅

2020-05-29

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！单片双药HIV治疗药物多伟托®扩大适应症获批，延展至稳定转换HIV感染者

2022-05-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Science重磅：何时吃比吃得少更重要！在适当时间进食可延长寿命三分之一

2022-05-10

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！钇90树脂微球治疗结直肠癌肝转移介入手术获成功

2022-05-07

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

NEJM重磅证据：大面积急性脑梗也应该及时进行血管内治疗！

2022-05-04

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅里程碑：肺癌创新药第三代ALK抑制剂洛拉替尼在中国获批

2022-04-30

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

时隔6年！《中国居民膳食指南(2022)》重磅发布

2022-04-28

仁心济世 (审核中...)

前往app查看评论内容

#重磅#

又一重磅名单出炉！首都医科大学吴浩、阴赪宏等75人入选

2022-04-27

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Nature重磅：我国干细胞制备技术获重要突破！

2022-04-27

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Circulation：重磅研究！中国胸痛中心大数据揭示空气污染可迅速诱发ACS疾病！

2022-04-27

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用

2022-04-22

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！科技部再更新人类遗传资源管理Q&A

2022-04-18

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅预告 | 助力癌症防治！鹍远生物“4.15全国肿瘤防治宣传周”活动开启！

2022-04-17

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Lancet：柳叶刀重磅！全世界已有38亿人感染过新冠？

2022-04-17

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！《2022年新版乳腺癌诊疗指南》正式发布

2022-04-16

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

3月精品课top榜单重磅来袭！

2022-04-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

3月公开课Top榜单重磅来袭！

2022-04-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究

2022-04-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

AACR重磅：局部晚期或转移性胃/GEJ癌患者使用抗TTX-030联合化学免疫疗法的一线治疗的安全性有效性评估

2022-04-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效

2022-04-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

AACR重磅之KGOG 3046/TRU-D：度伐利尤单抗和曲美木单抗联合一线新辅助化疗治疗晚期卵巢癌患者的II期研究

2022-04-12

科室
- - 订阅+
  - 更多科室
工具
服务